[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2020-2025 Global Herceptin Biosimilar Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

June 2021 | 118 pages | ID: 2064CAF8F976EN
Maia Research

US$ 3,360.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Biological drugs are usually derived from living organisms and can come from many sources such as humans, animals, microorganisms, or yeasts. A biologically similar drug is a biological product. In addition to meeting other criteria stipulated by law, the data proves to be highly similar to biological drugs (reference drugs) that have been approved by the FDA, and has no clinical difference in terms of safety, purity, and efficacy. Herceptin Biosimilar is approved for all indications in the Herceptin label, including HER2-overexpressing breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).
This report elaborates the market size, market characteristics, and market growth of the Herceptin Biosimilar industry, and breaks down according to the type, application, and consumption area of Herceptin Biosimilar. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Herceptin Biosimilar in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Herceptin Biosimilar market covered in Chapter 13:
Biocon
Genor Biopharma
Gedeon Richter
The Instituto Vital Brazil
Celltrion
Mylan
AryoGen Biopharma
Amgen
Mabion
Roche

In Chapter 6, on the basis of types, the Herceptin Biosimilar market from 2015 to 2025 is primarily split into:
Breast Cancer
Colorectal Cancer
Leukemia
Lymphoma
Other

In Chapter 7, on the basis of applications, the Herceptin Biosimilar market from 2015 to 2025 covers:
Hospital & Clinics
Oncology Centers
Other

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 HERCEPTIN BIOSIMILAR MARKET - RESEARCH SCOPE

1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 HERCEPTIN BIOSIMILAR MARKET - RESEARCH METHODOLOGY

2.1 Methodology
2.2 Research Data Source
  2.2.1 Secondary Data
  2.2.2 Primary Data
  2.2.3 Market Size Estimation
  2.2.4 Legal Disclaimer

3 HERCEPTIN BIOSIMILAR MARKET FORCES

3.1 Global Herceptin Biosimilar Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
  3.2.1 Political Factors
  3.2.2 Economic Factors
  3.2.3 Social Factors
  3.2.4 Technological Factors
  3.2.5 Environmental Factors
  3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
  3.4.1 Risk Assessment on COVID-19
  3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
  3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 HERCEPTIN BIOSIMILAR MARKET - BY GEOGRAPHY

4.1 Global Herceptin Biosimilar Market Value and Market Share by Regions
  4.1.1 Global Herceptin Biosimilar Value ($) by Region (2015-2020)
  4.1.2 Global Herceptin Biosimilar Value Market Share by Regions (2015-2020)
4.2 Global Herceptin Biosimilar Market Production and Market Share by Major Countries
  4.2.1 Global Herceptin Biosimilar Production by Major Countries (2015-2020)
  4.2.2 Global Herceptin Biosimilar Production Market Share by Major Countries (2015-2020)
4.3 Global Herceptin Biosimilar Market Consumption and Market Share by Regions
  4.3.1 Global Herceptin Biosimilar Consumption by Regions (2015-2020)
  4.3.2 Global Herceptin Biosimilar Consumption Market Share by Regions (2015-2020)

5 HERCEPTIN BIOSIMILAR MARKET - BY TRADE STATISTICS

5.1 Global Herceptin Biosimilar Export and Import
5.2 United States Herceptin Biosimilar Export and Import (2015-2020)
5.3 Europe Herceptin Biosimilar Export and Import (2015-2020)
5.4 China Herceptin Biosimilar Export and Import (2015-2020)
5.5 Japan Herceptin Biosimilar Export and Import (2015-2020)
5.6 India Herceptin Biosimilar Export and Import (2015-2020)
5.7 ...

6 HERCEPTIN BIOSIMILAR MARKET - BY TYPE

6.1 Global Herceptin Biosimilar Production and Market Share by Types (2015-2020)
  6.1.1 Global Herceptin Biosimilar Production by Types (2015-2020)
  6.1.2 Global Herceptin Biosimilar Production Market Share by Types (2015-2020)
6.2 Global Herceptin Biosimilar Value and Market Share by Types (2015-2020)
  6.2.1 Global Herceptin Biosimilar Value by Types (2015-2020)
  6.2.2 Global Herceptin Biosimilar Value Market Share by Types (2015-2020)
6.3 Global Herceptin Biosimilar Production, Price and Growth Rate of Breast Cancer (2015-2020)
6.4 Global Herceptin Biosimilar Production, Price and Growth Rate of Colorectal Cancer (2015-2020)
6.5 Global Herceptin Biosimilar Production, Price and Growth Rate of Leukemia (2015-2020)
6.6 Global Herceptin Biosimilar Production, Price and Growth Rate of Lymphoma (2015-2020)
6.7 Global Herceptin Biosimilar Production, Price and Growth Rate of Other (2015-2020)

7 HERCEPTIN BIOSIMILAR MARKET - BY APPLICATION

7.1 Global Herceptin Biosimilar Consumption and Market Share by Applications (2015-2020)
  7.1.1 Global Herceptin Biosimilar Consumption by Applications (2015-2020)
  7.1.2 Global Herceptin Biosimilar Consumption Market Share by Applications (2015-2020)
7.2 Global Herceptin Biosimilar Consumption and Growth Rate of Hospital & Clinics (2015-2020)
7.3 Global Herceptin Biosimilar Consumption and Growth Rate of Oncology Centers (2015-2020)
7.4 Global Herceptin Biosimilar Consumption and Growth Rate of Other (2015-2020)

8 NORTH AMERICA HERCEPTIN BIOSIMILAR MARKET

8.1 North America Herceptin Biosimilar Market Size
8.2 United States Herceptin Biosimilar Market Size
8.3 Canada Herceptin Biosimilar Market Size
8.4 Mexico Herceptin Biosimilar Market Size
8.5 The Influence of COVID-19 on North America Market

9 EUROPE HERCEPTIN BIOSIMILAR MARKET ANALYSIS

9.1 Europe Herceptin Biosimilar Market Size
9.2 Germany Herceptin Biosimilar Market Size
9.3 United Kingdom Herceptin Biosimilar Market Size
9.4 France Herceptin Biosimilar Market Size
9.5 Italy Herceptin Biosimilar Market Size
9.6 Spain Herceptin Biosimilar Market Size
9.7 The Influence of COVID-19 on Europe Market

10 ASIA-PACIFIC HERCEPTIN BIOSIMILAR MARKET ANALYSIS

10.1 Asia-Pacific Herceptin Biosimilar Market Size
10.2 China Herceptin Biosimilar Market Size
10.3 Japan Herceptin Biosimilar Market Size
10.4 South Korea Herceptin Biosimilar Market Size
10.5 Southeast Asia Herceptin Biosimilar Market Size
10.6 India Herceptin Biosimilar Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 MIDDLE EAST AND AFRICA HERCEPTIN BIOSIMILAR MARKET ANALYSIS

11.1 Middle East and Africa Herceptin Biosimilar Market Size
11.2 Saudi Arabia Herceptin Biosimilar Market Size
11.3 UAE Herceptin Biosimilar Market Size
11.4 South Africa Herceptin Biosimilar Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 SOUTH AMERICA HERCEPTIN BIOSIMILAR MARKET ANALYSIS

12.1 South America Herceptin Biosimilar Market Size
12.2 Brazil Herceptin Biosimilar Market Size
12.3 The Influence of COVID-19 on South America Market

13 COMPANY PROFILES

13.1 Biocon
  13.1.1 Biocon Basic Information
  13.1.2 Biocon Product Profiles, Application and Specification
  13.1.3 Biocon Herceptin Biosimilar Market Performance (2015-2020)
13.2 Genor Biopharma
  13.2.1 Genor Biopharma Basic Information
  13.2.2 Genor Biopharma Product Profiles, Application and Specification
  13.2.3 Genor Biopharma Herceptin Biosimilar Market Performance (2015-2020)
13.3 Gedeon Richter
  13.3.1 Gedeon Richter Basic Information
  13.3.2 Gedeon Richter Product Profiles, Application and Specification
  13.3.3 Gedeon Richter Herceptin Biosimilar Market Performance (2015-2020)
13.4 The Instituto Vital Brazil
  13.4.1 The Instituto Vital Brazil Basic Information
  13.4.2 The Instituto Vital Brazil Product Profiles, Application and Specification
  13.4.3 The Instituto Vital Brazil Herceptin Biosimilar Market Performance (2015-2020)
13.5 Celltrion
  13.5.1 Celltrion Basic Information
  13.5.2 Celltrion Product Profiles, Application and Specification
  13.5.3 Celltrion Herceptin Biosimilar Market Performance (2015-2020)
13.6 Mylan
  13.6.1 Mylan Basic Information
  13.6.2 Mylan Product Profiles, Application and Specification
  13.6.3 Mylan Herceptin Biosimilar Market Performance (2015-2020)
13.7 AryoGen Biopharma
  13.7.1 AryoGen Biopharma Basic Information
  13.7.2 AryoGen Biopharma Product Profiles, Application and Specification
  13.7.3 AryoGen Biopharma Herceptin Biosimilar Market Performance (2015-2020)
13.8 Amgen
  13.8.1 Amgen Basic Information
  13.8.2 Amgen Product Profiles, Application and Specification
  13.8.3 Amgen Herceptin Biosimilar Market Performance (2015-2020)
13.9 Mabion
  13.9.1 Mabion Basic Information
  13.9.2 Mabion Product Profiles, Application and Specification
  13.9.3 Mabion Herceptin Biosimilar Market Performance (2015-2020)
13.10 Roche
  13.10.1 Roche Basic Information
  13.10.2 Roche Product Profiles, Application and Specification
  13.10.3 Roche Herceptin Biosimilar Market Performance (2015-2020)

14 MARKET FORECAST - BY REGIONS

14.1 North America Herceptin Biosimilar Market Forecast (2020-2025)
14.2 Europe Herceptin Biosimilar Market Forecast (2020-2025)
14.3 Asia-Pacific Herceptin Biosimilar Market Forecast (2020-2025)
14.4 Middle East and Africa Herceptin Biosimilar Market Forecast (2020-2025)
14.5 South America Herceptin Biosimilar Market Forecast (2020-2025)

15 MARKET FORECAST - BY TYPE AND APPLICATIONS

15.1 Global Herceptin Biosimilar Market Forecast by Types (2020-2025)
  15.1.1 Global Herceptin Biosimilar Market Forecast Production and Market Share by Types (2020-2025)
  15.1.2 Global Herceptin Biosimilar Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Herceptin Biosimilar Market Forecast by Applications (2020-2025)
LIST OF TABLES AND FIGURES

Figure Herceptin Biosimilar Picture
Table Herceptin Biosimilar Key Market Segments
Figure Study and Forecasting Years
Figure Global Herceptin Biosimilar Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Herceptin Biosimilar Value ($) and Growth Rate (2015-2020)
Table Global Herceptin Biosimilar Value ($) by Countries (2015-2020)
Table Global Herceptin Biosimilar Value Market Share by Regions (2015-2020)
Figure Global Herceptin Biosimilar Value Market Share by Regions in 2019
Figure Global Herceptin Biosimilar Production and Growth Rate (2015-2020)
Table Global Herceptin Biosimilar Production by Major Countries (2015-2020)
Table Global Herceptin Biosimilar Production Market Share by Major Countries (2015-2020)
Figure Global Herceptin Biosimilar Production Market Share by Regions in 2019
Figure Global Herceptin Biosimilar Consumption and Growth Rate (2015-2020)
Table Global Herceptin Biosimilar Consumption by Regions (2015-2020)
Table Global Herceptin Biosimilar Consumption Market Share by Regions (2015-2020)
Figure Global Herceptin Biosimilar Consumption Market Share by Regions in 2019
Table Global Herceptin Biosimilar Export Top 3 Country 2019
Table Global Herceptin Biosimilar Import Top 3 Country 2019
Table United States Herceptin Biosimilar Export and Import (2015-2020)
Table Europe Herceptin Biosimilar Export and Import (2015-2020)
Table China Herceptin Biosimilar Export and Import (2015-2020)
Table Japan Herceptin Biosimilar Export and Import (2015-2020)
Table India Herceptin Biosimilar Export and Import (2015-2020)
Table Global Herceptin Biosimilar Production by Types (2015-2020)
Table Global Herceptin Biosimilar Production Market Share by Types (2015-2020)
Figure Global Herceptin Biosimilar Production Share by Type (2015-2020)
Table Global Herceptin Biosimilar Value by Types (2015-2020)
Table Global Herceptin Biosimilar Value Market Share by Types (2015-2020)
Figure Global Herceptin Biosimilar Value Share by Type (2015-2020)
Figure Global Breast Cancer Production and Growth Rate (2015-2020)
Figure Global Breast Cancer Price (2015-2020)
Figure Global Colorectal Cancer Production and Growth Rate (2015-2020)
Figure Global Colorectal Cancer Price (2015-2020)
Figure Global Leukemia Production and Growth Rate (2015-2020)
Figure Global Leukemia Price (2015-2020)
Figure Global Lymphoma Production and Growth Rate (2015-2020)
Figure Global Lymphoma Price (2015-2020)
Figure Global Other Production and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Herceptin Biosimilar Consumption by Applications (2015-2020)
Table Global Herceptin Biosimilar Consumption Market Share by Applications (2015-2020)
Figure Global Herceptin Biosimilar Consumption Share by Application (2015-2020)
Figure Global Hospital & Clinics Consumption and Growth Rate (2015-2020)
Figure Global Oncology Centers Consumption and Growth Rate (2015-2020)
Figure Global Other Consumption and Growth Rate (2015-2020)
Figure North America Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table North America Herceptin Biosimilar Consumption by Countries (2015-2020)
Table North America Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure North America Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure United States Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Canada Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Mexico Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Europe Herceptin Biosimilar Consumption by Countries (2015-2020)
Table Europe Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Europe Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Germany Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure France Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Italy Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Spain Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Herceptin Biosimilar Consumption by Countries (2015-2020)
Table Asia-Pacific Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure China Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Japan Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South Korea Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure India Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Herceptin Biosimilar Consumption by Countries (2015-2020)
Table Middle East and Africa Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure UAE Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South Africa Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Figure South America Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table South America Herceptin Biosimilar Consumption by Countries (2015-2020)
Table South America Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure South America Herceptin Biosimilar Consumption Market Share by Countries (2015-2020)
Figure Brazil Herceptin Biosimilar Market Consumption and Growth Rate (2015-2020)
Table Biocon Company Profile
Table Biocon Production, Value, Price, Gross Margin 2015-2020
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2015-2020
Table Genor Biopharma Company Profile
Table Genor Biopharma Production, Value, Price, Gross Margin 2015-2020
Figure Genor Biopharma Production and Growth Rate
Figure Genor Biopharma Value ($) Market Share 2015-2020
Table Gedeon Richter Company Profile
Table Gedeon Richter Production, Value, Price, Gross Margin 2015-2020
Figure Gedeon Richter Production and Growth Rate
Figure Gedeon Richter Value ($) Market Share 2015-2020
Table The Instituto Vital Brazil Company Profile
Table The Instituto Vital Brazil Production, Value, Price, Gross Margin 2015-2020
Figure The Instituto Vital Brazil Production and Growth Rate
Figure The Instituto Vital Brazil Value ($) Market Share 2015-2020
Table Celltrion Company Profile
Table Celltrion Production, Value, Price, Gross Margin 2015-2020
Figure Celltrion Production and Growth Rate
Figure Celltrion Value ($) Market Share 2015-2020
Table Mylan Company Profile
Table Mylan Production, Value, Price, Gross Margin 2015-2020
Figure Mylan Production and Growth Rate
Figure Mylan Value ($) Market Share 2015-2020
Table AryoGen Biopharma Company Profile
Table AryoGen Biopharma Production, Value, Price, Gross Margin 2015-2020
Figure AryoGen Biopharma Production and Growth Rate
Figure AryoGen Biopharma Value ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Production, Value, Price, Gross Margin 2015-2020
Figure Amgen Production and Growth Rate
Figure Amgen Value ($) Market Share 2015-2020
Table Mabion Company Profile
Table Mabion Production, Value, Price, Gross Margin 2015-2020
Figure Mabion Production and Growth Rate
Figure Mabion Value ($) Market Share 2015-2020
Table Roche Company Profile
Table Roche Production, Value, Price, Gross Margin 2015-2020
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Production by Types (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Production Share by Types (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Value ($) by Types (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Value Share by Types (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Consumption by Applications (2020-2025)
Table Global Herceptin Biosimilar Market Forecast Consumption Share by Applications (2020-2025)


More Publications